CONTEXT AND OBJECTIVE: Some studies have suggested a wide range of possible mechanisms through which probiotics may play a role in diabetes prevention and treatment. However, the underlying mechanisms are not fully understood. We conducted this study to review the potential mechanisms suggested for the effect of probiotics in diabetes. DESIGN AND SETTING: Narrative review conducted at the Food Security Research Center of Isfahan. METHODS: A search in the electronic databases MEDLINE (PubMed), Cochrane Library, Web of Science and Google scholar was performed up to October 2016.
INTRODUCTION
Probiotics are live microorganisms that may exert beneficial effects regarding the sufficiency of consumption via their impact on the microbial balance of the gut. 1 The most commonly used probiotics are Lactobacillus, Bifidobacterium and Saccharomyces boulardii, which have different effects depending on the dosage, length of therapy and administration route. 2 Given the influence of the gut microbiota on metabolic conditions including diabetes and on improving host metabolism, the concept of manipulating the gut microbiota has gained considerable interest over recent years. Use of probiotics has been suggested as one of the approaches towards modifying the clonal flora. 3 Diabetes mellitus is a chronic metabolic disease with major complications largely influenced by glycemic measures. 1 The Global
Burden of Disease 2015 study (GBD 2015) showed that diabetes was among the leading causes of years of life lost (YLLs) in most regions. 2 Also, diabetes was shown to be a leading cause of disability-adjusted life years (DALYs), for which the observed burden exceeded expected levels in many localities. 3 The rise in diabetes prevalence is set to pose one of the most important challenges to healthcare systems over the coming years. 4 A growing body of evidence suggests that favorable associations exist between probiotic consumption and metabolic profile among diabetes subjects. 5 However, the potential mechanisms secretion from enteroendocrine L-cells to improve carbohydrate metabolism, decrease glucotoxicity and increase insulin sensitivity of target cells. 6 Other proposed mechanisms to explain the action of probiotics on diabetes relate to anti-inflammatory, antioxidant and immunomodulatory effects and alteration of the expression of some genes involved in diabetes. [7] [8] [9] [10] Moreover, probiotic intake affects the structure of the gut flora, which might improve the integrity of the intestinal epithelium, weaken the immune responses and diminish the toll-like receptor 4 pathway, which in turn reduces pro-inflammatory signaling and enhances insulin sensitivity. 11, 12 Given the various statements regarding the effects of probiotics on diabetes that have been made, the aim of the present study was to focus on possible mechanisms for probiotics that might explain some of their beneficial effects in relation to diabetes, in the form of a review.
OBJECTIVE
The aim of the present study was to focus on possible mechanisms for probiotics that might explain some of their beneficial effects in relation to diabetes, in the form of a narrative review.
METHODS

Search strategy
A search of the electronic databases MEDLINE (via PubMed) and Cochrane Library (via Wiley) and the electronic repositories Web of Science and Google Scholar was performed. The search was last performed in October 2016, using combinations of search terms including "probiotics" OR "probiotic" OR "lactic acid bacteria" OR "lactobacillus" OR "lactobacilli" OR "bifidobacterium" OR "bifidobacteria" AND "diabetes mellitus", without any restrictions, in order to find studies focusing on the mechanisms linking probiotics with diabetes.
Eligibility criteria
Studies were included if they assessed the effect of a single or combination of live probiotics on diabetes. On the other hand, studies presented only as abstracts with no full-text available, non-English literature, studies involving patients with other metabolic diseases such as obesity or hypercholesterolemia, studies with no probiotic genus/strains reported, studies using synbiotics (i.e. probiotics combined with prebiotics), study protocols, pilot studies, letters, editorials, obviously irrelevant studies and studies that included non-diabetic patients or animals were all excluded.
Selection strategy
The eligibility of all potential studies identified for inclusion was independently assessed by two reviewers. Discrepancies regarding study inclusion were resolved through discussion with a third reviewer.
Initially, titles and abstracts were verified and then an assessment of full texts was conducted. The reference lists of eligible articles or relevant review papers were screened for other eligible papers.
Data extraction
Study characteristics from eligible articles such as the first author's name, year of publication, study design, subjects or animal models, probiotic strain and suggested mechanisms for probiotics on diabetes were extracted by two authors. The details of all eligible articles are outlined in Table 1 .
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RESULTS
Our initial search retrieved 1,214 articles. After removing duplicates, 704 titles and abstracts were screened. Then, from among these articles, 83 full texts were assessed for eligibility. Finally, 30 studies were included in this review. A flowchart of the study selection process is illustrated in Figure 1 .
Local effects of probiotics in the intestine
Endotoxemia (increased circulatory levels of bacterial lipopolysaccharides) has been identified as a triggering factor for insulin 
Bifidobacterium lactis HY8101
• increasing the mRNA expressions of pp-1, GLUT4, and PPAR-γ, and decreasing the mRNA expressions of GSK-3β, and G6PC (all involved in glucose metabolism and insulin sensitivity) Zhang et al. 22 Experimental study. HFS diet-induced pre-insulin resistance and a low dose-STZ HFS rats
Lactobacillus casei
• microbiota-based bile acid-chloride exchange mechanism: decrease in the number of bile acid 7α-dehydroxylating activity possessing bacteria, bile acid elimination, upregulating of chloride ion-dependent genes (ClC1-7, GlyRa1, SLC26A3, SLC26A6, GABAAa1, bestrophin-3 and CFTR) and prevention of chloride ion loss Li et al. 23 Experimental study.
Type 2 diabetes in rats
Lactobacillus plantarum NCU116
• increasing short-chain fatty acids (SCFA) such as butyric acid in colon which leads to the growth of lactobacilli and bifidobacteria and in lowering intestinal pH and to increased GLP-1 secretion • mRNA upregulation of glucose transporter-4 (GLUT-4) and regulation of the expression of PPAR-α and PPAR-γ Bejar et al. 24 Experimental study.
Alloxan-induced diabetes in rats
Lactobacillus plantarum TN627
• decreasing serum α-amylase activity, thus limiting the process of carbohydrate hydrolysis and absorption • inducing a change in the cytokine secretion pattern from a pro-inflammatory to an anti-inflammatory profile by means of gut-associated lymphoid tissue (GALT) Tabuchi et al. 36 Experimental study.
Streptozotocin-induced diabetic rats
Lactobacillus GG
• using glucose as a source of nutrition or by controlling the intestinal flora balance and through similar activity such as indigestible fiber, thus affecting glucose absorption • suppressing oxidative stress Matsuzaki et al. 37 Experimental study.
Alloxan-induced diabetic mice
Lactobacillus casei
• preventing nitric oxide production (free radical) and ß-cell destruction in islets of Langerhans • increasing erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity and total antioxidant status (TAS) shown that the beneficial effects of probiotic interventions on glucose tolerance and insulin sensitivity were related to increased levels of GLP-1.
Also, administration of Lactobacillus kefiranofaciens M and
Lactobacillus kefiri K was found to stimulate GLP-1 production, with a concomitant decrease in the numbers of Gram-negative bacteria, which could trigger inflammation. 19 The influence of human lactobacilli engineered to secrete GLP-1 on hyperglycemia has been investigated by Duanet al. 14 They showed that these lactobacilli reprogram intestinal cells into glucose-responsive insulin-secreting cells and that they therefore had the ability to ameliorate hyperglycemia and diabetes.
Moreover, in some studies, the effect of probiotics on diabetes has been linked to increases in the levels of short-chain fatty acids (SCFAs), especially butyrate in the colon. 23 Another study 26 indicated that administration of Lactobacillus plantarum No. 14 prevents development of insulin resistance, mainly through reducing accumulations of visceral fat, which prevents production of pro-inflammatory adipokines. Pro-inflammatory adipokines interfere with the insulin-signaling pathway of peripheral tissues and facilitate development of insulin resistance.
In addition, there is evidence that oral treatment with VSL#3, a probiotic compound containing bifidobacteria, lactobacilli and
Streptococcus salivarius subsp. thermophilus, induces a change in the cytokine secretion pattern from a pro-inflammatory to an antiinflammatory profile in the gut-associated lymphoid tissue (GALT), which is associated with qualitative modification of islet-specific destructive autoimmunity and, possibly, diabetes prevention. 35 Consistent with the abovementioned data, protective action
by Lactobacillus casei in relation to diabetes was correlated with less frequent onset of inflammation, through lowered levels of IL6, CRP and neutrophils in blood. 31 Lactobacillus casei also has the potential to decrease blood glucose levels through improvement of disordered post-immune responses via inhibition of production of IL2 and interferon gamma (INF-γ) and reduction of the increases in CD3+ and CD4+ T cell counts. 38 Kingma et al. 29 showed that Lactobacillus johnsonii (Ljo) N6.2 stimulates the innate immune response through activation of the membrane-bound receptors expressed in intestinal epithelial cells.
These receptors activate type 1 interferon (INF), which are key players in innate immunity. Therefore, a higher state of immunological activation would be achieved, thereby preventing diabetes. Moreover, this strain inhibits type 1 diabetes through mediating T-helper 17 (Th17) bias within the mesenteric lymph nodes.
Retention of the Th17 differentiation state, without conversion to a Th1 state, which is critical to diabetogenesis, prevents or delays the onset of type 1 diabetes. The effects of probiotics on oxidative stress
In diabetes, the free radicals that are generated cause lipid peroxidation and malondialdehyde (MDA) production. Moreover, the activity levels of reactive oxygen species scavengers are lower in patients with diabetes. Therefore, improvement of oxidative stress status may contribute towards diabetes management. 42, 43 Tabuchi et al. 36 showed that Lactobacillus GG lowered the level of MDA per gram of liver weight, which conferred suppression of oxidative stress and improved glucose tolerance.
Other authors concluded that the inhibitory effect of
Lactobacillus casei on the incidence of diabetes was partially dependent on prevention of nitric oxide production, given that this is a free radical that is involved in the ß-cell destruction process in islets of Langerhans. 37, 44 On the other hand, foods containing probiotics have been shown to protect against indices relating to diabetes. In one study, probiotic yogurt consumption increased the activity levels of erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx), which scavenge free radicals, and improved the total antioxidant status (TAS). 39 Another mechanism that was proposed to explain the action of fermented milk products containing probiotic bacteria on diabetes was through diminishing the elevation of thiobarbituric acidreactive substances and increasing glutathione levels in the liver and pancreatic tissues of diabetic rats. These findings indicated that this drink had good antioxidant properties. 33 Probiotic milk has consistently been found to exert antioxidant effects through inhibiting lipid peroxidation and preserving the activity of antioxidant enzymes, including SOD, GPx and catalase (CAT).
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The effects of probiotics on gene expression
Some studies on interactions between probiotics and gene expression have suggested that type 2 diabetes in rats is ameliorated through mRNA upregulation of glucose transporter-4 (GLUT-4)
through Lactobacillus plantarum NCU116 treatment. 23 This has a critical role in glucose uptake. 45 Moreover, NCU can regulate glucose homeostasis and insulin sensitivity in diabetic rats via regulating PPAR-α and PPAR-γ gene expression. These genes play key roles in inflammation and glucose homeostasis. 46 Bifidobacterium spp. also has an impact on enhanced expression of proteins involved in the insulin-signaling pathway, including IR-β, IRS-1 and Akt. This results in improved glucose uptake and blood glucose reduction. 16 Zhang et al. 22 In addition, it is important to take into consideration the risk of bias across different studies, such as publication, performance and reporting bias, along with potential conflicts of interest. Such factors might limit the ability to draw robust conclusions from these studies. Given that we only had limited access to some databases such as Embase, and that studies not reported in English were excluded, it is possible that more rigorous reporting of study results would improve the quality of the evidence in further studies.
Nonetheless, elucidation of the mechanisms linking the microbiome to diabetes can provide a rational basis for dietary consumption of probiotic microorganisms in relation to diabetes. In addition, evaluation of the mechanism of action for probiotics both in healthy subjects and in diabetic patients, so as to address the influence of these microorganisms on gene expression for different pathways, is needed in order to better understand the role that probiotics might have in prevention and treatment of diabetes.
CONCLUSIONS
In conclusion, there is some evidence suggesting various potential mechanisms of action for probiotics in relation to diabetes prevention and treatment. Further studies are needed to confirm the underlying pathways involved in the beneficial effects from each strain, along with assessment of other confounding factors. 
